1-3 of 3
Rene A.W. van Lier, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Attacking Oncogene Addiction in B-CLL: Seliciclib First Engages the Mcl-1/Noxa Axis, after Which Gradual Exhaustion of Bcl-2 Protection Leads to Bax Activation.

Delfine Y.H. Hallaert, Rene Spijker, Margot Jak, Annelieke Jaspers, Ingrid A.M. Derks, Nuno L. Alves, Drs, Jan Paul de Boer, Daphne de Jong, MD, Simon R. Green, Rene A.W. van Lier, MD, PhD, Marinus H.J. van Oers, MD, PhD, Eric Eldering, PhD
Journal: Blood
Blood (2006) 108 (11): 2103.
https://doi.org/10.1182/blood.V108.11.2103.2103
Published: 2006
Journal Articles

Redirection of CMV Specific CTL towards B-CLL Via CD20 Targeted HLA/CMV Complexes.

Rogier Mous, MD, Philip Savage Savage, MD, Ester BM Remmerswaal, Rene A.W. van Lier, MD, PhD, Eric Eldering, Marinus H.J. Van Oers, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 449.
https://doi.org/10.1182/blood.V106.11.449.449
Published: 2005
Journal Articles

Autologous CMV-Specific T Cells as Effector Cells in Immunotherapy of B Cell Chronic Lymphocytic Leukemia.

Arnon P. Kater, MD, Esther E.B.M Remmerswaal, Martijn A. Nolte, PhD, Eric Eldering, PhD, Rene A.W van Lier, MD. PhD, Marinus H.J van Oers, MD PhD
Journal: Blood
Blood (2004) 104 (11): 2512.
https://doi.org/10.1182/blood.V104.11.2512.2512
Published: 2004